At4g27290 Antibody

What is AT4G27290 and why is it significant in plant research?

AT4G27290 encodes an S-locus lectin protein kinase family protein in Arabidopsis thaliana, a model plant organism widely used in molecular biology research . This protein belongs to a family involved in various signaling pathways that regulate plant development and stress responses. S-locus proteins are particularly known for their roles in self-incompatibility mechanisms and plant-pathogen interactions. Understanding AT4G27290's function through antibody-based detection methods can provide insights into plant signaling networks, stress responses, and developmental processes.

What specifications should researchers know about commercially available AT4G27290 antibodies?

AT4G27290 antibodies are typically available as polyclonal antibodies raised against recombinant AT4G27290 protein. According to available data, these antibodies are commonly produced in rabbits and purified using antigen affinity methods . Key specifications include:

These specifications are critical for experimental planning and validation strategies .

What core applications are AT4G27290 antibodies validated for?

AT4G27290 antibodies have been validated primarily for ELISA and Western Blot applications . In Western Blot analyses, these antibodies can detect the native AT4G27290 protein in plant tissue extracts, allowing researchers to study protein expression levels across different tissues or experimental conditions. ELISA applications enable quantitative assessment of AT4G27290 protein levels with higher throughput. While not explicitly validated for other techniques, experienced researchers might adapt these antibodies for immunoprecipitation, immunohistochemistry, or immunofluorescence after appropriate validation studies.

What storage and handling precautions are essential for maintaining AT4G27290 antibody performance?

To maintain optimal performance of AT4G27290 antibodies, store them at -20°C or -80°C immediately upon receipt . Critical handling considerations include:

• Avoid repeated freeze-thaw cycles, which can degrade antibody quality and reduce binding efficiency

• Prepare working aliquots upon initial thawing to minimize freeze-thaw events

• When working with the antibody, keep it on ice or at 4°C

• Return to -20°C/-80°C promptly after use

• Monitor storage conditions regularly to ensure freezer stability

• Document all freeze-thaw events in laboratory records to track potential causes of reduced performance

Proper storage and handling significantly impact experimental reproducibility and extend the functional lifespan of the antibody.

How should specificity validation be conducted for AT4G27290 antibodies?

Rigorous validation of AT4G27290 antibody specificity is essential for generating reliable research data. A comprehensive validation strategy should include:

• Western blot analysis with positive and negative controls:

  • Positive control: Wild-type Arabidopsis thaliana tissue expressing AT4G27290

  • Negative control: AT4G27290 knockout/knockdown plant lines

  • Size verification: Confirm band appears at the expected molecular weight (check UniProt entry O81832)

• Peptide competition assay:

  • Pre-incubate antibody with excess recombinant AT4G27290 protein

  • If specific, this should abolish or significantly reduce signal in subsequent assays

• Cross-reactivity testing:

  • Test antibody against related S-locus lectin protein kinase family members

  • Evaluate performance in other plant species if cross-reactivity is claimed

• Orthogonal method validation:

  • Compare protein expression results with transcript levels via RT-PCR

  • Correlate findings with phenotypic data from AT4G27290 mutant lines

This systematic approach ensures that signals detected in experiments genuinely represent AT4G27290 and not related proteins or artifacts.

What fixation protocols optimize AT4G27290 antibody performance in immunolocalization studies?

Fixation methods significantly impact epitope accessibility and antibody binding. When designing immunolocalization studies for AT4G27290:

• Compare fresh versus fixed samples: Evidence from mass cytometry studies indicates that fixation can alter surface epitopes and unpredictably change antibody expression patterns . For AT4G27290, direct comparison between fresh and fixed samples is recommended:

  • Fresh samples maintain native epitope conformation but offer limited experimental flexibility

  • Fixed samples provide stability but may alter epitope accessibility

• Optimize fixation parameters:

  • Test multiple fixative concentrations (e.g., 1.6%, 2.0%, 2.4% formaldehyde)

  • Evaluate different fixation durations (15, 20, 30 minutes)

  • Consider dual fixation with formaldehyde followed by methanol for membrane proteins

• Epitope retrieval techniques:

  • Heat-mediated retrieval (citrate buffer, pH 6.0)

  • Enzymatic retrieval (proteinase K treatment)

  • Different pH conditions for buffer systems

• Documentation of optimal conditions:

  • Record precise fixation parameters that yield optimal signal-to-noise ratio

  • Maintain consistency across experimental replicates

Research suggests fixation with 1.6% formaldehyde for 20 minutes may be a reasonable starting point based on protocols used in related studies .

How can AT4G27290 antibodies be integrated into mass cytometry workflows?

Mass cytometry offers high-parameter single-cell analysis capabilities that could be valuable for plant cell signaling studies. To integrate AT4G27290 antibodies into mass cytometry experiments:

• Metal conjugation strategy:

  • Conjugate AT4G27290 antibodies to rare earth metals using commercial conjugation kits (e.g., MaxPar X8)

  • Select metal isotopes that minimize potential signal overlap with other markers in your panel

  • Validate conjugated antibodies against unconjugated controls

• Panel design considerations:

  • Include AT4G27290 within broader panels targeting related signaling proteins

  • Incorporate cell type markers to identify specific plant cell populations

  • Include functional markers to correlate AT4G27290 expression with cellular states

• Barcoding approach:

  • Implement two-tier barcoding strategies similar to those used in immune monitoring experiments

  • Use palladium-based barcoding for fixed samples

  • Consider CD45-inspired plant-specific barcoding approaches for live cells

• Data analysis pipeline:

  • Utilize specialized algorithms like FlowSOM for clustering cell populations

  • Apply dimensionality reduction (t-SNE) for visualization

  • Calculate percent positive events using appropriate controls and thresholds

Careful validation is particularly important when adapting antibodies to new platforms like mass cytometry.

What strategies can address non-specific binding issues with AT4G27290 antibodies?

Non-specific binding is a common challenge when working with plant antibodies due to complex plant matrices and potential cross-reactivity. For AT4G27290 antibodies, implement these methodological refinements:

• Blocking optimization:

  • Test multiple blocking agents (BSA, non-fat milk, plant-specific blockers)

  • Increase blocking time (1-3 hours) and concentration (3-5%)

  • Consider adding 0.1-0.3% Triton X-100 to reduce hydrophobic interactions

• Antibody dilution optimization:

  • Perform titration experiments with serial antibody dilutions (1:500 to 1:5000)

  • Identify optimal concentration that maximizes specific signal while minimizing background

• Washing protocol refinements:

  • Increase washing duration and number of washes

  • Add detergents at appropriate concentrations (0.05-0.1% Tween-20)

  • Consider high-salt washes (up to 500 mM NaCl) for electrostatic interference reduction

• Pre-adsorption protocol:

  • Pre-adsorb antibody with plant extract from AT4G27290 knockout lines

  • Remove antibodies binding to non-specific epitopes before experimental use

• Sample preparation adjustments:

  • Remove phenolic compounds and other plant-specific interfering substances

  • Consider protein extraction methods optimized for membrane-associated proteins

Document all optimization steps systematically to establish a reproducible protocol for your specific experimental system.

How can researchers investigate contradictory results from AT4G27290 antibody experiments?

When faced with contradictory results using AT4G27290 antibodies, implement this systematic troubleshooting approach:

• Antibody validation reassessment:

  • Verify antibody lot-to-lot consistency

  • Re-validate specificity using knockout controls

  • Confirm proper storage/handling hasn't compromised antibody quality

• Technical variables analysis:

  • Document and compare all experimental conditions between contradictory results

  • Control for differences in sample preparation, fixation, or processing

  • Standardize protein extraction methods across experiments

• Biological variables consideration:

  • Evaluate plant growth conditions, developmental stages, and stress exposures

  • Consider circadian regulation of protein expression

  • Assess genetic background differences in plant lines

• Orthogonal method validation:

  • Employ alternative antibodies targeting different epitopes of AT4G27290

  • Use genetic approaches (transgenic reporters, CRISPR editing)

  • Apply transcript analysis to correlate with protein findings

• Quantitative analysis refinement:

  • Implement rigorous statistical analyses appropriate for sample size

  • Normalize data consistently across experiments

  • Consider blind analysis to minimize expectation bias

This methodological framework helps distinguish genuine biological variability from technical artifacts when results appear contradictory.

What quality control metrics should be monitored across AT4G27290 antibody experiments?

To ensure experimental reliability, monitor these key quality control metrics:

• Signal-to-noise ratio (SNR):

  • Calculate SNR for each experiment using consistent methodology

  • Establish minimum acceptable threshold (typically >3:1)

  • Track SNR across experiments to identify performance trends

• Positive and negative control performance:

  • Include standardized positive controls (known AT4G27290-expressing tissues)

  • Incorporate negative controls (knockout lines, pre-immune serum controls)

  • Document control performance quantitatively across experiments

• Technical replicate consistency:

  • Calculate coefficient of variation between technical replicates (<15% ideal)

  • Establish acceptance criteria for replicate variability

  • Flag experiments exceeding variability thresholds for further investigation

• Antibody performance tracking:

  • Monitor sensitivity and specificity metrics over antibody lifetime

  • Document freeze-thaw cycles and storage conditions

  • Create control charts to visualize performance trends

• Cross-experiment calibration:

  • Include standard reference samples across experimental batches

  • Normalize batch effects using appropriate statistical approaches

  • Consider barcoding strategies similar to mass cytometry approaches

How should quantitative western blot data for AT4G27290 be analyzed?

Rigorous quantitative analysis of AT4G27290 western blot data requires:

• Appropriate normalization strategy:

  • Normalize to stable reference proteins (NOT housekeeping genes without validation)

  • Validate stability of reference proteins across experimental conditions

  • Consider total protein normalization (Ponceau, REVERT, Stain-Free) as alternatives

• Linear dynamic range verification:

  • Generate standard curves using recombinant AT4G27290 protein

  • Confirm sample measurements fall within linear detection range

  • Adjust exposure times or sample loading to ensure linearity

• Statistical analysis workflow:

  • Apply appropriate statistical tests based on experimental design

  • Account for biological and technical variation sources

  • Consider hierarchical analysis approaches for complex designs

• Replicate handling:

  • Distinguish between technical and biological replicates

  • Minimum of 3 biological replicates recommended

  • Address outliers using pre-established criteria and transparent reporting

• Densitometry best practices:

  • Use consistent region-of-interest selection methodology

  • Subtract local background for each lane

  • Avoid saturation in image acquisition

What approaches enable integration of AT4G27290 protein data with transcriptomic datasets?

Integrating AT4G27290 antibody-derived protein data with transcriptomic datasets requires sophisticated analytical approaches:

• Correlation analysis framework:

  • Calculate Spearman or Pearson correlations between protein and transcript levels

  • Visualize relationships using scatter plots with regression analysis

  • Identify conditions where protein-mRNA relationships diverge

• Multi-omics integration strategies:

  • Apply dimension reduction techniques (PCA, t-SNE) to combined datasets

  • Utilize dedicated multi-omics integration tools (mixOmics, MOFA)

  • Implement network analysis to identify co-regulated genes/proteins

• Temporal analysis considerations:

  • Account for time delays between transcription and translation

  • Design time-course experiments with appropriate sampling intervals

  • Apply time-series analysis methods for dynamic processes

• Condition-specific regulation identification:

  • Segment analysis by experimental conditions or tissues

  • Identify scenarios with post-transcriptional regulation

  • Develop hypotheses about regulatory mechanisms

• Visualization approaches:

  • Create integrated heatmaps displaying both protein and transcript data

  • Develop pathway visualizations incorporating both data types

  • Design custom plots highlighting condition-specific relationships

This methodological framework enables researchers to distinguish transcriptional and post-transcriptional regulation of AT4G27290 and formulate mechanistic hypotheses about its function.

How can cell-type specific expression of AT4G27290 be accurately determined?

Determining cell-type specific expression patterns of AT4G27290 requires specialized methodological approaches:

• Single-cell analysis adaptation:

  • Apply flow cytometry or mass cytometry approaches for plant cell suspensions

  • Establish appropriate gating strategies for plant cell populations

  • Calculate percent positive events using threshold approaches similar to those in mass cytometry studies

• Tissue-specific immunohistochemistry:

  • Optimize tissue fixation and embedding for plant tissues

  • Implement antigen retrieval protocols specific to plant cell walls

  • Develop quantitative scoring systems for expression intensity

• FACS-based approaches:

  • Isolate specific cell populations using fluorescence-activated cell sorting

  • Combine with cell-type specific promoter-reporter lines

  • Analyze AT4G27290 expression in purified populations

• Spatial transcriptomics correlation:

  • Correlate antibody staining patterns with spatial transcriptomics data

  • Validate protein localization against transcript distribution

  • Develop computational methods to align different data modalities

• Protoplast-based approaches:

  • Generate protoplasts from specific tissues

  • Apply flow cytometry with AT4G27290 antibodies

  • Calculate expression distributions across cell populations

These methodological approaches provide complementary data about the cell-type specificity of AT4G27290 expression, offering insights into its function within plant tissue architecture.

What emerging technologies might enhance AT4G27290 protein research?

Several emerging technologies show promise for advancing AT4G27290 protein research:

• Proximity labeling approaches:

  • Adapt BioID or APEX2 systems for in vivo identification of AT4G27290 interaction partners

  • Create fusion proteins to map protein interaction networks

  • Validate interactions using co-immunoprecipitation with AT4G27290 antibodies

• Advanced imaging technologies:

  • Super-resolution microscopy for precise subcellular localization

  • Live-cell imaging using tagged AT4G27290 variants

  • Correlative light and electron microscopy for ultrastructural context

• Mass spectrometry integration:

  • Develop targeted proteomics assays for absolute quantification

  • Identify post-translational modifications using phospho-proteomics

  • Map protein complexes through native mass spectrometry

• Single-cell proteomics:

  • Adapt emerging single-cell proteomic technologies to plant systems

  • Profile AT4G27290 across heterogeneous cell populations

  • Correlate with single-cell transcriptomics data

• CRISPR-based functional genomics:

  • Create precise genetic variants to test antibody epitope specificity

  • Develop inducible protein depletion systems

  • Engineer tagged endogenous proteins for antibody-independent validation

Thoughtful integration of these emerging technologies with traditional antibody-based approaches will provide more comprehensive understanding of AT4G27290's biological functions and regulatory mechanisms.